gain
Navigation Links
gain at medicine technology
RTA 402 Shown to Protect Animals Against Toxicities of Standard Cancer Treatments
IRVING, Texas--(BUSINESS WIRE)--Jun 29, 2007 - ReataPharmaceuticals, Inc. today announced the presentation of newpreclinical data showing their lead anti-cancer agent, theSynthetic Triterpenoid RTA 402, is effective at protecting againstcommon toxicities caused by traditional cancer treatments. Thisdata was presented at the annual meeting of the MultinationalAssociation of Supportive Care i...Results also show significant additional protection againstinfection with virus types beyond 16 and 18 with the GSK cervicalcancer candidate vaccine PHILADELPHIA, June 27, 2007 /PRNewswire-FirstCall/ -- Resultsfrom an interim analysis of a Phase III study show thatCERVARIX(R), the GlaxoSmithKline cervical cancer candidate vaccine,provides up to 100 percent protection against advanced prec...
Pre-Clinical Results Demonstrate Potential of ONCONASE forTreatment of Neuroblastoma BLOOMFIELD, N.J., June 27, 2007 /PRNewswire-FirstCall/ --Alfacell Corporation today announced that new data show ONCONASE,the company's lead drug candidate, is active against naive andchemoresistant neuroblastoma cells. The pre-clinical in vitro and in vivo data published in CancerLetters (2007; Vo...
New Flu Vaccine from PepTcell Could Provide Immunity Against All Strains of Influenza Virus
HIGH WYCOMBE, UK 18th June 2007-Previously undisclosedpre-clinical data showing how a new flu vaccine has the potentialto protect against all strains of influenza, including pandemic andannual, was presented today by PepTcell, at the 2007 Options forthe Control of Influenza VI (Options) Conference, in Toronto,Canada. The pre-cli...New Flu Vaccine From PepTcell Could Provide Immunity Against All Strains of Influenza Virus
Data Presented at Leading Influenza Conference HIGH WYCOMBE, England, June 18, 2007 /PRNewswire/ -- Previouslyundisclosed pre-clinical data showing how a new flu vaccine has thepotential to protect against all strains of influenza, includingpandemic and annual, was presented today by PepTcell, at the 2007Options for the Control of Influenza VI (Options) Conference, inToronto, Canada....Study Results Published in Cancer Research TARRYTOWN, N.Y., June 15, 2007 /PRNewswire-FirstCall/ -- EpiCeptCorporation today announced the results of scientific studies that(1) demonstrate that Azixa(TM) (MPC-6827) is effective in treatingmultiple types of human tumors in animal models, (2) reveal amechanism by which MPC-6827 exerts its effects, and (3) show thatMPC-6827 is not affected b...
EAST BRUNSWICK, N.J.--(BUSINESS WIRE)--Jun 6, 2007 - SavientPharmaceuticals, Inc. (NASDAQ: SVNT) announced today that twoabstracts exploring Phase 2 Puricase(R) (PEG-uricase) data andquality of life in treatment-failure gout patients will bepresented at the European League Against Rheumatism (EULAR) 2007Annual Congress taking place June 13 - 16th in Barcelona, Spain.Puricase is a PEGylated...
Study Presented at Second International Conference on AvianInfluenza at France's Pasteur Institute PARIS, June 01, 2007 /PRNewswire-FirstCall/ -- Very low doses ofNovavax Inc.'s pandemic influenza vaccine provided protectionagainst a lethal challenge of live H5N1 viruses, according topre-clinical data presented here today at the Second InternationalConference on Avian Influenza in Humans....
VIENNA, Va., May 23, 2007 /PRNewswire-FirstCall/ -- CEL-SCICORPORATION announces that CEL-1000 increased the immune responseagainst H5 avian influenza antigen in combination with MAS-1, awater-in-oil adjuvant delivery system. These findings werepresented on May 23, 2007 by Dr. Daniel Zimmerman, Senior VicePresident of Research, Cellular Immunology at CEL-SCI at theAmerican Society of Mic...
Innovative Cancer Drug MabThera Again Shown To Improve Survival Rates In Patients With Lymphoma
Adding MabThera to first line chemotherapy significantlyincreases patients_ overall survival BASEL, Switzerland (21 May, 2007) _ In a study publishedyesterday in the Journal of Clinical Oncology, MabThera (rituximab)plus chemotherapy (MCP*) was shown to significantly improvesurvival in patients with follicular lymphoma (FL) compared tochemotherapy alone.1 Follicular lymphoma is the...Clinical Poster Presented at Society for Investigative Dermatology FREEPORT, N.Y., May 16, 2007 /PRNewswire/ -- AGI Dermaticsrecently announced new comparative clinical data that indicatesthat OCTN-1 skin cells have the ability to recognize, transport andutilize L-ergothioneine (EGT) as a protector against oxidativedamage, and importantly, that (EGT) acts as a more powerful andefficient a...
WEST HAVEN, Conn.--(BUSINESS WIRE)--May 7, 2007 - NanoViricides,Inc. (Pink Sheets: NNVC) presented results of recent animal studiesagainst rabies and BSL3 in vitro studies against a Clade 2 H5N1(avian influenza) virus at the 23rd Annual Symposium of the PanAmerican Society for Clinical Virology in Tampa, FL, on Wednesday,May 2. (Pan American Society for Clinical Virology (PASCV):Clinical Vi...
ANX-201 Drug Combination Demonstrates Synergistic Activity Against Human and Bird Flu Viruses
ADVENTRX Presents Results at International Conference on AntiviralResearch SAN DIEGO, May 03, 2007 /PRNewswire-FirstCall/ -- ADVENTRXPharmaceuticals, Inc. , a biopharmaceutical research anddevelopment company focused on commercializing proprietary productcandidates for the treatment of cancer and infectious diseases,announced today that it presented results demonstrating synergisticactiv...BOZEMAN, Mont., May 01, 2007 /PRNewswire/ -- LigoCytePharmaceuticals presented preclinical data today showing thatimmunization with their influenza virus-like particles (VLPs)induced heterosubtypic protection in a virus challenge study. Thecompany's data were presented by Dr. Joel Haynes, LigoCyte's seniordirector of vaccine development, at the Tenth Annual Conference onVaccine Research...
Cethromycin Shown Effective Against Anthrax in Study
Advanced Life Sciences Achieves Key Endpoint in Primate Study CHICAGO, May 02, 2007 /PRNewswire-FirstCall/ -- Advanced LifeSciences Holdings, Inc. today announced that its novel respiratoryantibiotic, Cethromycin, was shown to be effective in preventinginhalation anthrax infection. This conclusion was reached from aprimate study where a 30-day course of oral Cethromycin was 100%protective...VIENNA, Va., May 01, 2007 /PRNewswire-FirstCall/ -- CEL-SCICORPORATION announces that CEL-1000 alone increased the immuneresponse against hepatitis B antigen, and that the combination ofCEL-1000 with MAS-1, a proprietary water-in-oil adjuvant deliverysystem owned by Mercia Pharma, induced highly significant increasesin specific anti-HBV (hepatitis B virus) antibodies. These findingswere...
New study results also show evidence of additional protectionagainst infection with other cancer-causing virus types LOS ANGELES, April 17, 2007 /PRNewswire-FirstCall/ -- TheGlaxoSmithKline cervical cancer candidate vaccine, CERVARIX(R),demonstrated 100 percent efficacy in preventing precancerouslesions due to cancer-causing human papillomavirus types 16 and 18for up to 5.5 years in an ex...
CALGARY, April 17, 2007 /PRNewswire-FirstCall/ - OncolyticsBiotech Inc. ("Oncolytics") announces that a poster by Dr. MaureenE. Lane et al. of , New York, entitled "In Vivo Synergy betweenOncolytic Reovirus and Gemcitabine in Ras-Mutated Human HCT116Xenografts" is scheduled to be presented today at the AmericanAssociation for Cancer Research (AACR) Annual Meeting in LosAngeles, CA. The m...
Abbott Researchers Focus on New Cutting-Edge Approaches in the Fight Against Cancer
Scientists to Present Data on Innovative Oncology Compounds at theAmerican Association for Cancer Research Annual Meeting ABBOTT PARK, Ill., April 13, 2007 /PRNewswire-FirstCall/ -- Fordecades, scientists have looked for new therapies that targetcancer. Researchers now know that cancer cells have several uniquecharacteristics -- they require new blood vessels to deliver oxygenand nutrient...ANA380 Exhibits Activity In Vitro Against Multiple Clinically Relevant Hepatitis B Virus Mutants
Poster Presentation at EASL on April 13, 2007, 2007 SAN DIEGO, and SEOUL, South Korea, April 13/PRNewswire-FirstCall/ -- Anadys Pharmaceuticals, Inc. and LG LifeSciences, Ltd., presented data from an in vitro study showing thatANA380 (LB80380) retains potency against multiple mutant strains ofhepatitis B virus (HBV) which are resistant to lamivudine,adefovir, entecavir or telbivudine, dur...Chief Scientist to Present Results at 2007 American Association forCancer Research Annual Meeting CLEVELAND, April 09, 2007 /PRNewswire-FirstCall/ -- ClevelandBioLabs, Inc. , announced today the results of its study ofProtectan CBLB502's efficacy as a mitigator of bothgastrointestinal (GI) and hematopoietic (bone marrow/bloodproduction) radiation-induced damage in non-human primates. The...
New Data Confirm That Use of Levemir Can Limit Weight Gain
COPENHAGEN, April 3, 2007-Newly published results in theInternational Journal of Clinical Practice(1) from the large-scale,observational ‘PREDICTIVE™ study’*, confirm thatLevemir® for the majority of people effectively treats diabeteswithout causing weight gain.(1) The PREDICTIVE™ study is examining patient outcomes whenLevemir® – a long-acting...- Studies Reinforce Astellas Commitment to Overcoming CriticalShortage of New Antimicrobial Agents MUNICH, Germany, April 02, 2007 /PRNewswire/ --Study resultspresented at the 17th European Congress of Clinical Microbiologyand Infectious Diseases (ECCMID) show that the antibiotictelavancin, and the antifungal micafungin, both have the potentialto meet a significant unmet need in th...
Viral Enzyme Recruited in Fight Against Ear Infection
St. Jude Study Success in Using Virus Enzyme to Treat Mouse Modelof Acute Otitis Media Suggests that Nasal Spray Could Be Used toPrevent Both Ear Infection and Pneumonia in People with Influenza MEMPHIS, Tenn., March 22, 2007 /PRNewswire/ -- Parents might oneday give their children a weekly treatment with a nasal spray ofvirus enzymes to prevent them from getting a severe middle earinfect...Scottish Scientists Test ‘Secret Weapon’ Against Tumours
LONDON, March 8, 2007--Cancer Research UK scientists in Glasgowhave devised a new method of attacking cancer cells. They reportthe findings in the Journal of Clinical Investigation* today(Thursday). A team of scientists from the Beatson Institute for CancerResearch gave mice a chemical that caused cancer cells to commitsuicide, significantly slowing the growth of the tumours they w...Other TagstectectectectectecLogLogLogLogLogLogLogLogLogLogPerfectprepOther Contentsexcisionexcisionexcisionexcisionexcisionexcisionexcisionsupportsupportsupportsupportsupportsupportsupportsupportsupportsupportsuppositorysurfactantsurfactantsurfactantsurfactantsurgerysurgerysurgerysurgerysurgerysurgerysurgerysurgerysurgicalsurgicalsurgicalsurgicalsurgicalsurgicalsurgicalsurgical
DisposablestecDigestsMicroorganismsMicroinjectionICSISpermatocyteAdhererentLocatingLogmicrogridCompatibilityUVettePerfectprep
(Date:9/4/2008)...entists define ,a gene, in different ways, so it c...arious ways of framing the concept of a gene, acco... issue of EMBO reports . , The study, Frame that... British and Norwegian newspapers: The Guardian, T...sten, Dagbladet, and VG from Norway. , The resea...
(Date:9/4/2008)...versary of the September 11 attacks approaches, th... podcast describing an array of technologies to he...The podcast is the sixth episode in ACS,s acclaime..., With new episodes posted twice monthly, Global...ety in the 21st Century, and explains how chemists...
(Date:9/4/2008)...the tuna population? Can we compute how to transit...uction? , Those and other questions will be tack..., economists, biologists and environmental scienti...tute for Computational Sustainability, being launc...ence Foundation (NSF). This program is designed to...
(Date:9/4/2008)...ring the success of an unprecedented experiment in...nthropists Eli and Edythe Broad announced today th...ad Institute of Harvard and MIT to $600 million. A...n, the Broads today gave an endowment of $400 mill...hed as a 10-year "venture" experiment, into a perm...
Breaking Biology News(10 mins):What is a gene? 2New 'chemical radar' among national security innovations in ACS podcast 2New 'chemical radar' among national security innovations in ACS podcast 3Cornell gets $10 million NSF grant to establish new sustainability institute 2Eli and Edythe L. Broad make unprecedented gift to endow Broad Institute of Harvard & MIT 2Eli and Edythe L. Broad make unprecedented gift to endow Broad Institute of Harvard & MIT 3Eli and Edythe L. Broad make unprecedented gift to endow Broad Institute of Harvard & MIT 4Eli and Edythe L. Broad make unprecedented gift to endow Broad Institute of Harvard & MIT 5ExploreDairy com Debuts With Information on Minnesota Dairy Events People and Products 20567 1ExploreDairy com Debuts With Information on Minnesota Dairy Events People and Products 20567 2ESMO Conference Lugano 20565 1ESMO Conference Lugano 20565 2XanGo Introduces 3SIXTY5 28TM 29 Whole Food Nutrition Multi Vitamin 20563 1XanGo Introduces 3SIXTY5 28TM 29 Whole Food Nutrition Multi Vitamin 20563 2XanGo Introduces 3SIXTY5 28TM 29 Whole Food Nutrition Multi Vitamin 20563 3Kroger and The Little Clinic Establish Partnership to Offer Customers Convenient Healthcare Centers Inside Their Neighborhood Store 20561 1Kroger and The Little Clinic Establish Partnership to Offer Customers Convenient Healthcare Centers Inside Their Neighborhood Store 20561 2Kroger and The Little Clinic Establish Partnership to Offer Customers Convenient Healthcare Centers Inside Their Neighborhood Store 20561 3(Date:9/5/2008)... New York Fashion Week,s Annual Destination to Fe...rk, New York (PRWEB) September 5, 2008 -- http:/...title__ American Laser], the largest provider of l...services in the U.S., announces sponsorship of the...E360, from Sept. 7-10, serves as the alternative F...
(Date:9/4/2008)...case-control study, the presence of measles virus ... GI disturbances than in children with only GI dis...et were unrelated to MMR vaccine timing. Study fi...of Science on September 4 ( http://dx.plos.org/10...lementation of measles vaccines in 1963, three to ...
(Date:9/4/2008)...labeling about fungal infection risk , ,...alth authorities have asked the manufacturers of f... safety warnings on the risk of developing opportu...Cimzia, Enbrel and Remicade, belong to a class of ...lockers (TNF-alpha blockers), which suppress the i...
(Date:9/4/2008)...Palestinian and Israeli teenagers, art from,Artsbr.../ -- America must take a major,role in finding pea...orld,says Ira Magaziner, chair of the William J. ...White House Advisor for Policy Development in the ...eaker at a conference at,Massachusetts School of P...
Breaking Medicine News(10 mins):Health News:American Laser Centers Sponsors STYLE360 to Share the Skinny on Body Shaping 2Health News:Study firmly shows no connection between measles, mumps, rubella (MMR) vaccine and autism 2Health News:Study firmly shows no connection between measles, mumps, rubella (MMR) vaccine and autism 3Health News:FDA Demands Tougher Warnings on Immunosuppressive Drugs 2Health News:FDA Demands Tougher Warnings on Immunosuppressive Drugs 3Health News:Ira Magaziner Joins Leaders in Peace Psychology at MSPP to Explore Ways to Transform Violence, Heal Families, Communities and World 2Health News:Ira Magaziner Joins Leaders in Peace Psychology at MSPP to Explore Ways to Transform Violence, Heal Families, Communities and World 3Health News:Ira Magaziner Joins Leaders in Peace Psychology at MSPP to Explore Ways to Transform Violence, Heal Families, Communities and World 4[0] American Laser Centers Sponsors STYLE360 to Share the Skinny on Body Shaping[0] Study firmly shows no connection between measles, mumps, rubella (MMR) vaccine and autism[0] FDA Demands Tougher Warnings on Immunosuppressive Drugs[0] Ira Magaziner Joins Leaders in Peace Psychology at MSPP to Explore Ways to Transform Violence, Heal Families, Communities and World
| Copyright © 2003-2008 Bio-Medicine. All rights reserved. ABOUT | CONTACT US | DISCLAIMER | PRIVACY POLICY | TERMS AND CONDITIONS |  |